The Bank of Nova Scotia has taken a significant step by filing a preliminary pricing supplement for its Autocallable Contingent Coupon Barrier Notes. This offering is designed to attract investors by providing a unique investment opportunity linked to the performance of specific stocks.

Filed on November 5, 2026, the pricing supplement outlines the details of the notes, which are set to mature on November 23, 2029. The notes are linked to the performance of AbbVie Inc. and Alphabet Inc., making them particularly appealing to investors looking for exposure to these companies.

The filing indicates that these notes are unsubordinated and unsecured obligations of the bank, which means they carry certain risks, including credit risk associated with the bank itself. This offering is part of the bank's broader strategy to diversify its funding sources and engage with a wider range of investors.

Background

The Bank of Nova Scotia, also known as Scotiabank, operates primarily in the state commercial banking sector, classified under SIC code 6022. The bank trades under the ticker symbol BNS on the New York Stock Exchange (NYSE). Its recent filings include multiple forms leading up to this preliminary pricing supplement, including various 424B2 and FWP forms filed on November 4, 2026.

What the Filing Says

The filing provides essential details about the notes, stating, "The information in this Preliminary Pricing Supplement is not complete and may be changed." It emphasizes that the notes will not be sold until the pricing supplement is finalized.

Additionally, the notes are subject to investment risks, including the credit risk of the Bank of Nova Scotia. The filing also outlines that the notes will be automatically called if the closing value of the reference assets meets certain conditions, offering potential returns based on the performance of AbbVie and Alphabet stocks.

Impact

This offering may significantly impact investors looking for innovative financial products. It highlights the bank's commitment to providing unique investment opportunities, which could attract both retail and institutional investors. Furthermore, it may influence competitors in the state commercial banking sector to explore similar offerings to remain competitive.

What's Next

The filing does not specify what happens next regarding the offering. Investors and market observers will likely await further details in the final pricing supplement, which will provide more clarity on the terms and conditions of the notes.